Personaland Medical History
Jane is a 37-year-old white female who has been in excellent healthcondition until she developed flu-like symptoms. Jane lost her motherwho was 65 years old due to congestive heart failure while her fatherdied at the age of 49 because of myocardial infarction. Following thedevelopment of the symptoms, Jane sought medical help. She wassubjected to a chest x-ray with the results indicating that she wassuffering from pulmonary venous congestion. An echocardiogramperformed indicated that her left ventricle was normal despite thesevere reduction of the systolic function with an estimation of 25%ejection fraction. Her clinical status has deterioratedsignificantly. She developed fevers, intermittent diarrhea, andpersistent nausea.
DrugTherapy, Treatment and Follow-up Care
The most appropriate diagnosis for the patient is arrhythmogenicright ventricular cardiomyopathy (Thiene, 2015). The condition ischaracterized by syncopal attacks and a flu-like illness. It is ahereditary disease associated with chromosomes 1, 2 and 14(Campuzano et al., 2013). The primary focus of therapy should bethe reduction of mortality through prevention of disease progression.Therapeutic options that can be introduced include lifestyle changes,catheter ablation and pharmacological treatment that include the useof antiarrhythmic agents and heart failure drug therapy (te Riele,Tandri, & Bluemke, 2014). The patient can present herself to theclinic periodically for follow-up care and evaluate the onset orprogress of her condition. Follow-up care should focus on monitoringthe morphological and functional abnormalities of the patient’sventricles (Basso, Corrado, Bauce, & Thiene, 2012).
Effectof Gender on Choice of Care
Gender determines the nature of care provided for the patient. Forexample, pharmacological interventions could affect normal metabolicactivities such as the hormonal system of the female. Because of thesame, a consideration ought to be made in suggesting the mostappropriate treatment regimen to be employed.
Basso, C., Corrado, D., Bauce, B., & Thiene, G. (2012).Arrhythmogenic right ventricular cardiomyopathy. Circulation:Arrhythmia and Electrophysiology, 5(6), 1233–1246.http://doi.org/10.1161/CIRCEP.111.962035
Campuzano, O., Alcalde, M., Allegue, C., Iglesias, A., García-Pavía,P., Partemi, S., … Brugada, R. (2013). Genetics of arrhythmogenicright ventricular cardiomyopathy. Journal of Medical Genetics,50(March), 280–9.http://doi.org/10.1136/jmedgenet-2013-101523
te Riele, A., Tandri, H., & Bluemke, D. a. (2014). Arrhythmogenicright ventricular cardiomyopathy (ARVC): cardiovascular magneticresonance update. Journal of Cardiovascular Magnetic Resonance,16(1), 50. http://doi.org/10.1186/s12968-014-0050-8
Thiene, G. (2015). The research venture in arrhythmogenic rightventricular cardiomyopathy: A paradigm of translational medicine.European Heart Journal.http://doi.org/10.1093/eurheartj/ehu493